Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Mupirocin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mupirocin SCHEMBL18995884 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL14022405 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL1027616 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL3291 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL15307512 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL15387504 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL18998277 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL15387505 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL19183296 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL14616863 | 1.00 | IARS1 (1.00) | IARS1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3655104-A1 | AN OSTEOADSORPTIVE FLUOROGENIC SUBSTRATE OF CATHEPSIN K FOR IMAGING OSTEOCLAST ACTIVITY AND MIGRATION | The Regents of the University of California (US) | 2020-05-27 | — | — | EP | disclosed |
| WO-2019018238-A1 | AN OSTEOADSORPTIVE FLUOROGENIC SUBSTRATE OF CATHEPSIN K FOR IMAGING OSTEOCLAST ACTIVITY AND MIGRATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-01-24 | — | — | WO | disclosed |
| EP-3344325-A1 | LOCAL ADMINISTRATION OF DRUGS FOR THE TREATMENT OF ASTHMA | Mercator Medsystems, Inc. (US) | 2018-07-11 | — | — | EP | disclosed |
| EP-3240800-A1 | CLOSTRIDIUM DIFFICILE TARGETING MOIETIES AND CONSTRUCTS COMPRISING SAID MOIETIES | C3 JIAN, LLC (US) | 2017-11-08 | — | — | EP | disclosed |
| EP-3166959-A1 | TARGETING PEPTIDES THAT BIND S. MUTANS, CONSTRUCTS COMPRISING SUCH PEPTIDES AND USES THEREOF | C3 Jian, Inc. (US) | 2017-05-17 | — | — | EP | disclosed |
| WO-2017040605-A1 | LOCAL ADMINISTRATION OF DRUGS FOR THE TREATMENT OF ASTHMA | MERCATOR MEDSYSTEMS, INC. (US) | 2017-03-09 | — | — | WO | disclosed |
| EP-3086646-A2 | PLANTS CONTAINING BENEFICIAL ENDOPHYTES | Indigo AG, Inc. (US) | 2016-11-02 | — | — | EP | disclosed |
| WO-2016133471-A1 | A TOPICAL COMPOSITION COMPRISING MUPIROCIN AND DEXPANTHENOL | PHARMACTİVE İLAÇ SANAYİ VE TİCARET A. Ş. (TR) | 2016-08-25 | — | — | WO | disclosed |
| WO-2016109443-A1 | CLOSTRIDIUM DIFFICILE TARGETING MOIETIES AND CONSTRUCTS COMPRISING SAID MOIETIES | C3 JIAN, INC. (US) | 2016-07-07 | — | — | WO | disclosed |
| WO-2016007551-A1 | TARGETING PEPTIDES THAT BIND S. MUTANS, CONSTRUCTS COMPRISING SUCH PEPTIDES AND USES THEREOF | C3 JIAN, INC. (US) | 2016-01-14 | — | — | WO | disclosed |
| WO-2015100432-A2 | METHOD FOR PROPAGATING MICROORGANISMS WITHIN PLANT BIOREACTORS AND STABLY STORING MICROORGANISMS WITHIN AGRICULTURAL SEEDS | SYMBIOTA, INC. (US) | 2015-07-02 | — | — | WO | disclosed |
| WO-2015100431-A2 | PLANTS CONTAINING BENEFICIAL ENDOPHYTES | SYMBIOTA, INC. (US) | 2015-07-02 | — | — | WO | disclosed |
| EP-2437596-A1 | SKIN TREATMENT COMPOSITIONS | Ex-Tek, LLC (US) | 2012-04-11 | — | — | EP | disclosed |
| WO-2011084882-A2 | METHODS AND COMPOSITIONS FOR ENHANCED IMMUNOLOGICAL THERAPY AND TARGETING OF GRAM-POSITIVE BACTERIA | CONTRAFECT CORPORATION (US) | 2011-07-14 | — | — | WO | disclosed |
| WO-2010141711-A1 | SKIN TREATMENT COMPOSITIONS | EX-TEK, LLC (US) | 2010-12-09 | — | — | WO | disclosed |